Evaluation some Biochemical Levels in Patients undergoing Hemodialysis in Baghdad Governorate


  • Hussein Faleh Hassen Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq. http://orcid.org/0000-0001-7615-1049
  • Makarim Qassim Dawood Al-Lami Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq.
  • Ali J Hashim Al-Saedi Nephrologist – Center, Kidney Diseases and Transplantation-Medical City, P.O. Box 61023, Baghdad, Iraq.


CRP, Hemodialysis, Blood serum, Leptin


The objective of investigating some biochemical parameters like urea, creatinine, Hb and other parameters as CRP and leptin in the serum of ESRD patients on hemodialysis pre-dialysis.

Method: Sample of 250 cases which consists of the patient with ESRD, their mean ages were 52.66 ± 12.55 years with ranged from 18-83. Moreover, under hemodialysis treatment not less than three months. Apparently, 20 healthy subjects were selected as (control) for comparison.

Results: The results showed that there was a significant increase (p<0.01) in the serum urea, creatinine, CRP, and leptin. While, revealed significant (p< 0.05) decrease in the levels of uric acid, serum glucose, albumin, inorganic phosphorus, potassium, Hb and platelet in patients before dialysis compared to the control group. Non-significant (p>0.05) is in total cholesterol, calcium and total protein in patients undergoing hemodialysis which was compared to the control group. It is concluded from the findings of the present study, it shows a highly significant increased serum concentration of leptin as well as, elevated serum values of CRP. Whereas a highly significant decrease in GFR and CrCl result from loss of the ability of the kidney to clearance. Also, abnormal mineral parameters and hematological parameters. According to the results of this study, serum total protein and cholesterol cannot be used, as a diagnostic marker of nutrition disorders in patients on regular hemodialysis requires further investigation and clarification.


Download data is not yet available.


Meyer, T.W. and Hostetter, T.H. (2007). Uremia. N. Engl. J. Med., 357(13): 1316-25.
[2]. Al-Khoury, S, Afzali, B, Shah, N., Thomas, S., Gusbeth-Tatomir, P., Goldsmith, D., Covic, A. (2007). Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? International Journal of Clinical Practice, 61: 281–289.
[3]. Kumar, S., Richard, B. and Debasish, B. (2014). Why do young people with chronic kidney disease die early? World J. Nephrol., 3(4): 143–155.
[4]. Mathenge, R.N., McLigeyo, S.O., Muita, A.K. and Otieno, L.S, (1993). The spectrum of echocardiographic finding in chronic renal failure. East African Medical Journal, 70(2): 97-103.
[5]. Sahin, H., Uyanik, F., Inanc, N. and Erdem, O. (2009). Serum zinc, plasma ghrelin, leptin levels, selected biochemical parameters and nutritional status in malnourished hemodialysis patients. Biol. Trace Elem. Res., 127(3): 191–9.
[6]. Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R., Burn, P. (1995). Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science, 269(5223): 546-9.
[7]. Sanjay, R., Kumar, Y., Babu, K., Hegde, S., Ballal, S. and Tatu, U. (2002). Evaluation of the role of serum leptin in hemodialysis patients. Indian J. Nephrol., 12: 69–72.
[8]. Bossola, M., Muscaritoli, M., Valenza. V., Panocchia, N., Tazza, L., Cas¬cino, A. Laviano, A., Liberatori, M., Lodovica Moussier, M., Rossi Fanelli, F. and Luciani, G. (2004). Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin. Pract., 97(3): c76–82.
[9]. Cooper, B.A., Branley, P., Bulfone, L., Collins, J.F., Craig, J.C., Fraenkel, M.B., Harris, A., Johnson, D.W., Kesselhut, J., Jing Li, J., Luxton, G., Pilmore, A., Tiller, D.J., Harris, D.C. and Pollock, C.A. (2010). A randomized controlled trial of early versus late initiation of dialysis. N, Engl. J. Med., 363: 609–619.
[10]. Nesrallah, G.E., Mustafa, R.A., Clark, W.F., Bass, A., Barnieh, L., Klarenbach, S., Quinn, R.R., Hiremath, S., Ravani, P., Sood, M.M., Moist, L.M. (2014). Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. Can. Med. Assoc. J., 186(2): 112-7.
[11]. Zilva, F., Pannall, P.R. and Mayne, P. (1994). Clinical chemistry in diagnosis and treatment, 6th ed., London, Arnold.
[12]. Schilthuizen, S., Batenburg, L., Simonis, F. and Vercauteren, F. (2015). Device for the removal of toxic substances from blood: Google Patents.
[13]. Karkar, A. (2012). Modalities of hemodialysis: Quality improvement. Saudi journal of kidney diseases and transplantation, 23 (6): 1145-1161.
[14]. Uchida, S. (2011). Differential Diagnosis of Chronic Kidney Disease (CKD): By primary diseases. JMAJ, 54(1): 22–26.
[15]. Ul Amin, N., Mahmood, R.T. and Asad, M.J., Zafar M. and Raja A.M. (2014). Evaluating Urea and Creatinine Levels in Chronic Renal Failure Pre and Post Dialysis: A Prospective Study. Journal of Cardiovascular Disease, 2(4): 182-185.
[16]. Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F. 3rd, Feldman, H.I., Kusek, J.W., Eggers, P., Van Lente, F., Greene, T., and Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 150 (9): 604–612.
[17]. Pierrat, A., Graveir, E., Saunders, C., Caira, M.W., Aït-Djafer, Z., Legras, B. and Mallié, J.P. (2003). Predicting GFR in children and adults: A comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int., 64(4): 1425–1436.
[18]. Mehdi, W.A., Al-Helfee, W., Abd-W. and Dawood, A.S. (2012). Study of several antioxidants, total acid phosphatase, prostatic acid phosphatase, total and free prostate-specific antigen in sera of Man with chronic kidney failure. Kerbala Journal of pharmaceutical sciences, 4: 155-165.
[19]. Porth, C.M. (2007). Essentials of pathology 2nd ed, Lippincott Williams & Wilkins, Philadelphia; p:559-574.
[20]. Farhan, O.L. (2013). Determination of Several Biochemical Markers in Sera of Patients with Kidney Diseases. Journal of Al-Nahrain University, 16 (3): 40-45.
[21]. Merzah, K.S. and Hasson, S.F. (2015). The Biochemical Changes in Patients with Chronic Renal Failure. International Journal of Pharma Medicine and Biological Sciences, 4(1): 75-79.
[22]. Hasan, D. (2015). Assessment of Hepcidin, Ferritin and CRP in Anemic End Stage Renal Disease Patients on Hemodialysis. Thesis, MSc, College of Medicine, University of Baghdad.
[23]. Hussien, N., Nearmeen, M., Amira, A., Myada, M., Marwa, A., and Nermin, R. (2016). Association of Serum Leptin with Inflammation, Anemia and Body Mass Index in Egyptian Chronic Hemodialysis Patients. International Journal of Advanced Research, 4(3): 1316-1328.
[24]. Montazerifar, F., Mansour, K., Zahra, H. and Mahla, P. (2015). Study of serum levels of leptin, C-reactive protein and nutritional status in hemodialysis patients. Iran Red Crescent Med. J., 17(8): e26880.
[25]. Kang, D.H. and Chen, W. (2011). Uric acid and chronic kidney disease: new understanding of an old problem. Semin. Nephrol., 31(5): 447-52.
[26]. Meenakshi, G.G. (2016). Effect of dialysis on certain biochemical parameters in chronic renal failure patients. IJCMR, 3(10): 2869-2871
[27]. Athab, A., Nabeel, K.M. and Luma, T.A. (2016). C-Reactive Protein and renal function tests in chronic renal failure patients on hemodialysis and kidney transplantation (June 30, 2016). IJMPS, 6(3): 51-60.
[28]. Adejumo, O.A., Okaka, E.I., Okwuonu, C.G., Iyawe, I.O., Odujoko, O.O. (2016). Serum C-reactive protein levels in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana Med. J., 50(1): 31-8.
[29]. Carrie, B.J., Golbetz, H.V., Michaels, A.S. and Myers, B.D. (1989). Creatinine: An inadequate filtration marker in glomerular disease. Am. J. Med., 69(2): 177-182.
[30]. Higgins, C. (2016). Urea and creatinine concentration, the urea:creatinine ratio, acutecaretesting.org, p 1–8.
[31]. Abdul Wahid, H. Kismat, M.T. and Asma, Y. (2006). Interleukin-6 Level in serum of Iraqi patients on maintenance hemodialysis therapy. J. Fac. Med. Baghdad, 48(4): 431-34.
[32]. Lefta, A. (2009). Biochemical study for some enzymes in sera of patients with renal failure in AL-Diwaniyah city. A Thesis, High Diploma College of Science, Karbala University.
[33]. Mason, P.D. and Pusey, C.D. (1994). Glomerulonephritis diagnosis and treatment. BMJ, 309(6968): 1557–1563.
[34]. Langenberg, C., Wan, L., Bagshaw, S.M. and Egi, M., May, C.N. and Bellomo, R. (2006). Urinary biochemistry in experimental acute renal failure. Nephrol. Dial. Transplant., 21: 3389-3397.
[35]. Kaysen, G.A. (2003). Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy? Kidney Int. Suppl., 64(87): 92–98.
[36]. Carrero, J.J., Stenvinkel, P., Cuppari, L., Ikizler, T.A., Kalantar-Zadeh, K., Kaysen, G., Mitch, W.E., Price, S.R., Wanner, C., Wang, A.Y., ter Wee, P., Franch, H.A. (2013). Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease?: A Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J. Ren. Nutr., 23(2): 77–90.
[37]. UK Prospective Diabetes study group (1998). "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 Diabetes: UKPDS 38". BMJ, 1998; 317:703.
[38]. Liebau, M.C., Braun, F., Höpker, K., Weitbrecht, C., Bartels, V., Müller, R-U., et al., (2013). Dysregulated Autophagy Contributes to Podocyte Damage in Fabry’s Disease. PLoS ONE, 8(5): e63506. https://doi.org/10.1371/journal.pone.0063506.
[39]. Chandna, S.M., Kulinskaya, E. and Farrington, K. (2005). A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol. Dial. Transplant., 20(10): 2130-2138.
[40]. Afshar, R., Sanavi, S., Izadi-Khah, A. (2007). Assessment of nutritional status in patients undergoing maintenance hemodialysis: A Single-Center Study from Iran. Saudi J. Kidney Dis. Transplant., 18(3): 397-404.
[41]. Sathiyanarayanan, S., Shankar M.P. and Prabhakar, E.R. (2013). Serum Lipid Profile in Chronic Renal Failure and Haemodialysis Patients. JCTMB, 1(3): 36-41.
[42]. Kaysen, G.A. (2001). The microinflammatory state in uremia: causes and potential consequences. J. Am. Soc. Nephrol., 12(7): 1549-1557.
[43]. Kaur, S., Singh, N.P., Jain, A.K. and Thakur A. (2012). Serum C-reactive protein and leptin for assessment of nutritional status in patients on maintenance hemodialysis. Indian J. Nephrol., 22(6): 419-23.
[44]. Vaziri, N.D. (2005). Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am. J. Physiol. Renal Physiol.; 290(2): F262-272.
[45]. Mustafa, A., Saba, Z. and Dhafer, S. (2008). Some biochemical changes in serum of hemodialysis patients. National Journal of Chemistry, 32: 695-700.
[46]. Baigent, C. and David, C.W. (2000). Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? Nephrol. Dial. Transplant, 15: 1118-1119.
[47]. Traynor, J.P., Thomson, P.C., Simpson, K., Ayansina, D.T., Prescott, G.J., Mactier, R.A. (2011). Comparison of patient survival in non-diabetic transplant-listed patients initially treated with haemodialysis or peritoneal dialysis. Nephrol. Dial. Transplant, 26(1): 245-252.
[48]. Sultan, A. (2011). Evaluation of hs-CRP, albumin and some trace elements in sera of patients with renal failure on hemodialysis. Thesis, M.Sc., College of Science, The University of AL-Mustansiriya.
[49]. Jumaah, I. (2013). A study of some biochemical parameters in blood serum of patients with chronic renal failure. Journal of Basrah Researches Sciences, 39(4): 20-32.
[50]. Shrishrimal, K., Hart, P., Michota, F. (2009). Managing diabetes in Hemodialysis Patients: Observations and Recommendations. Cleveland Clinic Journal of Medicine, 76(11): 649-655.
[51]. Viaene, L., Meijers, B.K., Vanrenterghem, Y. and Evenepoel, P. (2012). Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (Early-Stage) chronic kidney disease. Am. J. Nephrol., 35(5): 434–441.
[52]. Al-Rubae, I.S., Tariq, H. and Najlaa, Q. (2010). Free fatty acids and biochemical changes in Iraqi patients with chronic renal failure. Baghdad Science Journal, 7(1): 654-662.
[53]. Kalantar-Zadeh, K., Gutekunst, L., Mehrotra, R., Kovesdy, C.P., Bross, R., Shinaberger, C.S., Noori, N., Hirschberg, R., Benner, D., Nissenson, A.R., and Kopple, J.D. (2010). Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease. Clin. J. Am. Soc. Nephrol., 5(3): 519-30.
[54]. Freethi, R., A. Velayutha Raj, Kalavathy Ponniraivan, M., Rasheed Khan, A. Sundhararajan and Venkatesan (2016). Study of serum levels of calcium, phosphorus and alkaline phosphatase in chronic kidney disease. Int. J. Med. Res. Health Sci., 5(3): 49-56.
[55]. Abdul-Sattar, S. (2007). "Phosphatases and osteodystrophy in chronic renal failure as related to oxidative stress". Thesis, B.H.D., College of Science, The University of Baghdad.
[56]. Muftin, N. (2008). Biochemical changes in Iraqi patients with chronic renal failure after renal dialysis. Thesis, M.Sc., College of Science, The University of AL-Mustansiriya.
[57]. Sigrist, M.K., Taal, M.W., Bungay, P. and McIntyre, C.W. (2007). Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2(6): 1241-8.
[58]. Albaaj, F. and Hutchison, A.J. (2003). Hyperphosphatemia in renal failure: causes, consequences and current management. Drugs, 63(6): 577-96.
[59]. Bailie, G.R. and Pharm, D. (2004). Calcium and phosphorus management in chronic kidney disease: challenges and trends. Formulary, 39: 358-365.
[60]. Rastergar, A. and Soleimani, M. (2001). Hypokalaemia and hyperkalaemia. Postgrad. Med. J., 77: 759-64.
[61]. Ahmed, J. and Weisberg, L.S. (2001). Hyperkalemia in dialysis patients. Semin. Dial., 14(5): 348-56.
[62]. Williams, M.E. (2006). Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist’s perspective. Clin. J. Am. Soc. Nephrol., 1(2): 209-220.
[63]. Biesen, W.V., Vanholder, R., and Lameire, N. (2006). Defining acute renal failure: RIFLE and Beyond. Clin. J. Am. Soc. Nephrol., 1(6): 1314-19.
[64]. Sreenivasulu, U., Bhagyamma, S.N. and Anuradha, R. (2016). Study of serum electrolyte changes in end-stage renal disease patients before and after hemodialysis sessions: a hospital-based study. Sch. Acad. J. Biosci., 4(3B): 283-287.
[65]. Nagaraj, J., Venkatesh, D., Radhika, K., and Raju, S.V.R. (2014). Correlation of leptin levels and total body fat in patients with chronic kidney disease on hemodialysis. RJPBCS, 5(4): 789.
[66]. Johansen, K.L., Mulligan, K., Tai, V. and Schambelan, M. (1998). Leptin, Body Composition and Indices of Malnutrition in Patients on Dialysis. JASN, 9(6): 1080-4.
[67]. Beberashvili, I., Sinuani, I., Azar, A., Yasur, H., Feldman, L., Efrati, S., Averbukh, Z., Weissgarten, J. (2009). Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index. J. Ren. Nutr., 19(3): 238–247.
[68]. Tsujimoto. Y., Shoji, T., Tabata, T., Morita, A., Emoto, M., Nishizawa, Y., Morii, H. (1999). Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Am. J. Kidney Dis., 34(5): 832?8.
[69]. Babaei, Z., Moslemi, D., Parsian, H., Khafri, S., Pouramir, M., Mosapour, A. (2015). Relationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors. Journal of the Egyptian National Cancer Institute, 27(4): 223–229.
[70]. Stenvinkel, P., Heimburger, O. and Lonnqvist, F. (1997). Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol. Dial. Transplant, 12(7): 1321-1325.
[71]. Schwartz, M.W., Baskin, D.G., Bukowski, T.R., Kuijper, J.L., Foster, D., Lasser, G., Prunkard, D.E., Porte, D., Woods, S.C., Seeley, R.J. and Weigle, D.S. (1996). Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45(4): 531-535.
[72]. Nand, N., Aggarwal, H.K., Yadav, R.K., Gupta, A., and Sharma, M. (2009). Role of high sensitivity C-reactive protein as a marker of inflammation in pre-dialysis patients of chronic renal failure. JIACM, 10(1&2): 18-22.
[73]. Alghythan, A.K. and Alsaeed, A.H. (2012). Hematological changes before and after hemodialysis. J. Sci. Res. Essays, 7(4): 490-497.
[74]. Habib, A., Razi, A. and Sana, R. (2017). Hematological changes in patients of chronic renal failure and the effect of hemodialysis on these parameters. Int. J. Res. Med. Sci., 5(11): 4998-5003
[75]. Han, Y.S. and Kishimoto, T. (1997). Reticulocyte maturity index reflect erythropoietin effect in haemodialysis patients. Osaka City Med. J., 43(1): 69-76.
[76]. Eschbach, J.W. (1989). The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int., 35(1): 134-148.
[77]. Michael, R. and Bertil, G. (2004). Acquired nonimmune hemolytic disorders. In: John P. Greer, John Forester, John N. Lukens, George M. Rodgers and Frixos Paraskevas. Wintrobe’s clinical hematology. Eleventh edition, 1: chapter 38: 1239.
[78]. Robert, T. and Means Jr. (2004). Anemias secondary to chronic disease and systemic disorders. In: John P. Greer, John Forester, John N. Lukens, George M. Rodgers, Frixos Paraskevas and Bertil Glader. Wintrobe’s clinical hematology. Eleventh edition, Vol – 1, chapter 47: pp.1451-55.
[79]. Fishbane, S., Kalantar-Zadeh, K. and Nissenson, A.R. (2004). Serum ferritin in chronic kidney disease: Reconsidering the upper limit for iron treatment. Semin. Dial., 17(5): 336–341.
[80]. Eschbach, J.W. Jr, Funk, D., Adamson, J., Kuhn, I., Scribner, B.H. and Finch, C.A. (1967). Erythropoiesis in patients with renal failure undergoing chronic dialysis. N. Eng J. Med., 276(12): 653-8.
[81]. Ch. Gouva, E. Papavasiliou, K.P. Katopodis, A.P. Tambaki, D. Christidis and A.D. Tselepis (2006). Effect of erythropoietin on serum PAF-acetylhydrolase in patients with chronic renal failure. Nephrology dialysis transplantation, 21(5): 1270-77.
[82]. Wasti, A.Z., Sumaira, I., Naureen, F. and Saba, H. (2013). Hematological disturbances associated with Chronic Kidney Disease and kidney transplant patients. International Journal of Advanced Research, 1(10): 48-54.
[83]. Agarwal, R., Bills, J.E., Hecht, T.J., Light, R.P. (2011). Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension, 57(1): 29-38.




How to Cite

Hassen, H. F., Al-Lami, M. Q. D., & Al-Saedi, A. J. H. (2018). Evaluation some Biochemical Levels in Patients undergoing Hemodialysis in Baghdad Governorate. Journal of Advanced Laboratory Research in Biology, 9(2), 50–57. Retrieved from https://e-journal.sospublication.co.in/index.php/jalrb/article/view/32